Hypoxia signaling: Challenges and opportunities for cancer therapy

被引：31
|
作者：
Ivan, Mircea [1 ,2 ]
Fishel, Melissa L. [3 ,4 ]
Tudoran, Oana M. [5 ]
Pollok, Karen E. [3 ]
Wu, Xue [6 ]
Smith, Paul J. [7 ]
机构：
[1] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA
[3] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA
[4] IU Simon Comprehens Canc Ctr, Dept Pharmacol & Toxicol, Indianapolis, IN USA
[5] Oncol Inst Prof Dr Ion Chiricuta, Cluj Napoca, Cluj, Romania
[6] Ohio State Univ, Columbus, OH USA
[7] Cardiff Univ, Sch Med, Cardiff, Wales
来源：
SEMINARS IN CANCER BIOLOGY | 2022年 / 85卷
关键词：
Hypoxia; HIF1; HIF2; HIF inhibitors; Hypoxia-activated prodrug; SMALL-MOLECULE INHIBITOR; ANTI-ANGIOGENIC THERAPY; DNA TOPOISOMERASE-II; CYTOCHROMES P450 CYP; RENAL-CELL CARCINOMA; INDUCIBLE FACTOR; ACTIVATED PRODRUG; N-OXIDE; HEPATOCELLULAR-CARCINOMA; PROLYL HYDROXYLASE;
D O I：
10.1016/j.semcancer.2021.10.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Hypoxia is arguably the first recognized cancer microenvironment hallmark and affects virtually all cellular populations present in tumors. During the past decades the complex adaptive cellular responses to oxygen deprivation have been largely elucidated, raising hope for new anti cancer agents. Despite undeniable preclinical progress, therapeutic targeting of tumor hypoxia is yet to transition from bench to bedside. This review focuses on new pharmacological agents that exploit tumor hypoxia or interfere with hypoxia signaling and discusses strategies to maximize their therapeutic impact.
引用
收藏
页码：185 / 195
页数：11
相关论文
共 50 条
  • [1] Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
    Shant Qinxiang Sin
    Chakrabhavi Dhananjaya Mohan
    Robby Miguel Wen-Jing Goh
    Mingliang You
    Siddaiah Chandra Nayak
    Lu Chen
    Gautam Sethi
    Kanchugarakoppal Subbegowda Rangappa
    Lingzhi Wang
    Cancer and Metastasis Reviews, 2023, 42 : 741 - 764
  • [2] Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
    Sin, Shant Qinxiang
    Mohan, Chakrabhavi Dhananjaya
    Goh, Robby Miguel Wen-Jing
    You, Mingliang
    Nayak, Siddaiah Chandra
    Chen, Lu
    Sethi, Gautam
    Rangappa, Kanchugarakoppal Subbegowda
    Wang, Lingzhi
    CANCER AND METASTASIS REVIEWS, 2023, 42 (03) : 741 - 764
  • [3] A New Wave of Targeting 'Undruggable' Wnt Signaling for Cancer Therapy: Challenges and Opportunities
    Park, Woo-Jung
    Kim, Moon Jong
    CELLS, 2023, 12 (08)
  • [4] Cancer gene therapy; Challenges and opportunities
    Scanlon, KJ
    CANCER GENE THERAPY, 2004, 11 (12) : 842 - 842
  • [5] Cancer gene therapy: Challenges and opportunities
    Scanlon, KJ
    ANTICANCER RESEARCH, 2004, 24 (2A) : 501 - 504
  • [6] Organoids: opportunities and challenges of cancer therapy
    Jiang, Xianjie
    Oyang, Linda
    Peng, Qiu
    Liu, Qiang
    Xu, Xuemeng
    Wu, Nayiyuan
    Tan, Shiming
    Yang, Wenjuan
    Han, Yaqian
    Lin, Jinguan
    Xia, Longzheng
    Peng, Mingjing
    Tang, Yanyan
    Luo, Xia
    Su, Min
    Shi, Yingrui
    Zhou, Yujuan
    Liao, Qianjin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [7] Targeting hypoxia cell signaling for cancer therapy
    Giovanni Melillo
    Cancer and Metastasis Reviews, 2007, 26 : 341 - 352
  • [8] Targeting hypoxia cell signaling for cancer therapy
    Melillo, Giovanni
    CANCER AND METASTASIS REVIEWS, 2007, 26 (02) : 341 - 352
  • [9] Carbon Dots: Opportunities and Challenges in Cancer Therapy
    Bhattacharya, Tanima
    Shin, Gye Hwa
    Kim, Jun Tae
    PHARMACEUTICS, 2023, 15 (03)
  • [10] Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
    Silva, Valdenizia R.
    Neves, Sara P.
    Santos, Luciano de S.
    Dias, Rosane B.
    Bezerra, Daniel P.
    CANCERS, 2020, 12 (11) : 1 - 36
12345